Your browser doesn't support javascript.
loading
Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries.
Flammia, Rocco Simone; Hoeh, Benedikt; Chierigo, Francesco; Hohenhorst, Lukas; Sorce, Gabriele; Tian, Zhen; Leonardo, Costantino; Graefen, Markus; Terrone, Carlo; Saad, Fred; Shariat, Shahrokh F; Briganti, Alberto; Montorsi, Francesco; Chun, Felix K H; Gallucci, Michele; Karakiewicz, Pierre I.
Afiliação
  • Flammia RS; Department of Maternal-Child and Urological Sciences, Sapienza University Rome, Policlinico Umberto I Hospital, Rome, Italy.
  • Hoeh B; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Quebec, Canada.
  • Chierigo F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Quebec, Canada.
  • Hohenhorst L; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Sorce G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Quebec, Canada.
  • Tian Z; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Leonardo C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Quebec, Canada.
  • Graefen M; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Terrone C; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Quebec, Canada.
  • Shariat SF; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Briganti A; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Quebec, Canada.
  • Montorsi F; Department of Maternal-Child and Urological Sciences, Sapienza University Rome, Policlinico Umberto I Hospital, Rome, Italy.
  • Chun FKH; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Gallucci M; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Karakiewicz PI; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Curr Urol ; 16(4): 191-196, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36714227
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Curr Urol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Curr Urol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália